PROphet
®
PROphetNSCLC
TM
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical studies
Collaborators
About Us
News
In the news
Thought Leadership
Press releases
Meetings & Events
Awards
Contact Us
Careers
US openings
Israel openings
Order a test
PROphet
®
PROphetNSCLC
TM
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical Studies
Collaborators
News
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
Company
About us
Careers
Contact us
Order a test
In the News
Thought Leadership
Publications
Meetings & Events
Awards
In the News
September 13, 2024
OncoHost accepted to present poster at ESMO 2024
Read more
August 16, 2024
OncoHost announces three abstracts selected for presentation at WCLC 2024
Read more
July 30, 2024
Matching Patients with Treatments: Developing Clinically Meaningful Diagnostics To Inform Cancer-Immunotherapy Selection
Read more
August 2, 2024
Ninety-three percent of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test
Read more
August 5, 2024
Clinical Lung Cancer publishes study: 93% of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test
Read more
July 29, 2024
New Test Influences First-Line Therapy Decisions for Metastatic NSCLC Patients
Read more
June 18, 2024
Immunotherapy Month…and Much More
Read more
June 18, 2024
OncoHost: Finding New, Better Immunotherapies for Complex Cancers
Read more
May 27, 2024
Israeli Startup To Showcase AI Cancer Tool At Top Oncology Summit
Read more
May 27, 2024
PROphet Platform’s Predictive Ability to be Demonstrated
Read more
May 31, 2024
OncoHost To Present Poster Demonstrating PROphet®’s Application in Multiple Cancer Indications at ASCO 2024
Read more
June 10, 2024
Dana-Farber Cancer Institute and OncoHost partner for renal cell carcinoma research
Read more
June 12, 2024
Companies partner to identify biomarkers for renal cell carcinoma
Read more
June 3, 2024
OncoHost Launches Study on Biomarkers for Renal Cell Carcinoma
Read more
June 3, 2024
OncoHost and Dana-Farber Partner on Kidney Cancer (RCC) Biomarker Study
Read more
June 4, 2024
OncoHost announces new study on biomarkers for renal cell carcinoma
Read more
June 2, 2024
Leading Cancer institute Dana-Farber to partner with OncoHost for groundbreaking cancer study
Read more
May 17, 2024
OncoHost on liquid biopsy, AI, and developing Israel’s life sciences ecosystem
Read more
May 20, 2024
Biomed 2024 Showcases Israel’s Resilient Entrepreneurial Spirit
Read more
April 10, 2024
AI tool helps doctors pick optimum cancer treatment for patients
Read more
March 29, 2024
Observational study demonstrates clinical validity and utility of OncoHost’s PROphet NSCLC test
Read more
March 22, 2024
Study in JCO® Precision Oncology Validates Clinical Efficacy of OncoHost’s PROphet® NSCLC Test
Read more
March 21, 2024
Study Demonstrates Clinical Validity of OncoHost’s NSCLC Test
Read more
March 21, 2024
OncoHost Wins AI Excellence Award
Read more
February 26, 2024
Predicting immunotherapy success via biomarkers
Read more
February 22, 2024
New cancer research for personalized care
Read more
February 22, 2024
Study: Protein Indicates Likely Success of Cancer Immunotherapy
Read more
January 26, 2024
OncoHost’s CEO Is PROphet-ic About His Diagnostic’s Potential To Transform Care
Read more
January 15, 2024
OncoHost: Guiding oncology treatment decisions with one blood draw
Read more
January 4, 2024
Predicting Immune-Related Adverse Events Through Machine Learning With OncoHost: Dr. Waqas Haque, Dr. Matthew Hadfield, and Dr. Ofer Sharon
Read more
April 4, 2022
AI & Big Data - A Bright New Diagnosis? Roundtable
Read more
December 8, 2019
First-Of-Its-Kind Lab To Improve Personalized Cancer Therapy Opens In Israel
Read more
December 31, 2019
Israeli algorithm may predict if cancer patients will respond to treatment
Read more
January 21, 2020
OncoHost, RayBiotech Win $1M From BIRD Foundation
Read more
January 21, 2020
OncoHost, RayBiotech Awarded $1 Million Grant for Precision Oncology
Read more
February 5, 2020
Top 5 Recent Advances In Israeli Cancer Research And Treatment
Read more
February 10, 2020
Startup develops blood test that aims to undermine tumors’ resilience
Read more
February 18, 2020
Backed by EU funds, Israeli researcher tackles treatment-resistant cancer
Read more
February 23, 2020
$8m in BIRD grants go to Israeli-US collaborations in agtech and health
Read more
March 1, 2020
Personalized Cancer Treatment, A Real Possibility?
Read more
April 7, 2020
Developing Personalized Strategies To Maximize Cancer Therapy Success
Read more
June 4, 2020
PART 1: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients
Read more
June 4, 2020
PART 2: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients
Read more
August 7, 2020
By Next Year, Will Doctors Finally Have The Technology To Fully Personalize Treatments For Lung Cancer Patients?
Read more
October 6, 2020
OncoHost Data on Host Immunotherapy Response to be Presented This Week
Read more
November 4, 2020
Oncohost platform improves immunotherapy response predictions
Read more
November 12, 2020
Israeli blood test offers better choices to fight cancer
Read more
November 15, 2020
OncoHost Offers New Hope For Cancer Sufferers
Read more
December 8, 2020
Dr. Ofer Sharon, CEO of OncoHost – Interview Series
Read more
December 31, 2020
OncoHost - Personalized cancer therapy for more effective treatment
Read more
January 12, 2021
Nobel prizewinner Ciechanover hails ‘much more precise’ cancer treatment
Read more
January 19, 2021
Israeli Startup OncoHost Raises $8M For AI Precision Oncology Platform
Read more
January 19, 2021
Israel-based OncoHost closes $8M in Series B funding to provide personalized cancer therapy for more effective treatment
Read more
January 19, 2021
OncoHost Raises $8 Million in Series B Funding Round
Read more
January 19, 2021
OncoHost raises $8 million to develop AI that predicts cancer treatment responses
Read more
January 20, 2021
OncoHost Secures $8M in Series B Funding
Read more
January 20, 2021
The evolution of machine learning in oncology: an interview with Dr Ofer Sharon
Read more
January 21, 2021
Money on the Move: January 15-20
Read more
January 26, 2020
US-Israel Foundation To Invest $8M In 9 New Joint Initiatives
Read more
January 21, 2021
OurCrowd leads $8M Series B in Israeli personalized cancer therapy startup
Read more
January 22, 2021
Oncohost nabs $8M series B round for AI-powered precision oncology platform
Read more
January 22, 2021
OncoHost Secures $8 Million Series B Funding Round
Read more
January 26, 2021
Health IT Appointments and Hires
Read more
February 1, 2021
January 2021 smiles upon Israeli startups: 4 new Unicorns and over $1B in funding
Read more
February 17, 2021
Dr. Ofer Sharon, CEO of OncoHost, Discusses Technology to Improve Cancer Care
Read more
March 30, 2021
How an AI tool predicts responses to cancer treatment
Read more
May 21, 2021
Which Israeli technologies will soon be going to space?
Read more
June 14, 2021
The Impact of Technology on Healthcare
Read more
June 16, 2021
NHS opens eight UK clinical trial sites to assess cancer patient response to immunotherapy in collaboration with OncoHost
Read more
June 16, 2021
NHS Opens Eight UK Clinical Trial Sites to Assess Cancer Patient Response to Immunotherapy in Collaboration with OncoHost
Read more
June 16, 2021
NHS opens 8 clinical trial sites to assess cancer treatment
Read more
June 17, 2021
Israel’s OncoHost, UK’s NHS to study cancer patient responses to immunotherapies
Read more
June 22, 2021
Oncohost opens trial sites for study evaluating its AI proteomics profiling technology
Read more
July 6, 2021
OncoHost's Focus on the Patient Offers Precision Oncology to Combat Cancer
Read more
August 19, 2021
OncoHost awarded Best Practices Technology Innovation Leadership Award in the AI-based precision oncology industry by Frost & Sullivan
Read more
August 20, 2021
OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices
Read more
August 25, 2021
Israeli Startup OncoHost Eyeing 2022 Commercial Launch of Immunotherapy Response Prediction Test
Read more
September 20, 2021
OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response
Read more
September 20, 2021
Oncohost platform predicts response to lung cancer therapy
Read more
October 31, 2021
OncoHost’s Algorithms Predict Cancer Patients Response To Treatments
Read more
November 1, 2021
CTech’s 20 Minute Leaders Podcast Interview with Ofer Sharon, CEO of OncoHost
Read more
November 6, 2021
OncoHost: Personalizing cancer treatment based on host response
Read more
November 15, 2021
Dr. Ofer Sharon, CEO of OncoHost, Talks the Potential Impact of Precision Medicine on Cancer Therapy
Read more
December 1, 2021
OncoHost: David Gandara
Read more
December 7, 2021
Health IT Appointments and Hires
Read more
December 13, 2021
OncoHost, Heidelberg University Hospital Strike Lung Cancer Biomarker Alliance
Read more
December 16, 2021
Global Roundup: Aussie Biopharma Raises $25 Million to Expand in US
Read more
December 17, 2021
Israeli research institute makes great contributions to cancer research
Read more
December 20, 2021
OncoHost Collaborates with Lung Biobank Heidelberg to Discover Lung Cancer Biomarkers
Read more
January 17, 2022
OncoHost Announces Interim Results From PROPHETIC Trial, Multicenter Assessment Of NSCLC Patient Response To Immunotherapy
Read more
January 24, 2022
Space meat and hummus: Israel finalizes experiments for upcoming ISS mission
Read more
January 24, 2022
Next Israeli astronaut’s 35 experiments revealed
Read more
January 28, 2022
2022 Predictions for AI and Machine Learning in Healthcare
Read more
February 3, 2022
3 Researchers Developing Innovative Strategies In Cancer Therapy
Read more
March 1, 2022
Oncology Peer Review On-The-Go: Ofer Sharon, MD, Discusses OncoHost and PROPHETIC Trial for NSCLC
Read more
March 2, 2022
Tech Transfer Roundup: MD Anderson, Moffitt Lead Busy Academic Cancer Partnering Space
Read more
March 14, 2022
Lifting the veil of uncertainty around cancer treatments
Read more
March 16, 2022
Driving Progress in Personalized Cancer Therapy
Read more
March 23, 2022
Nobel laureate Prof. Aaron Ciechanover to discuss advances in precision medicine
Read more
April 5, 2022
OncoHost Announces AI-Based Clinical Trial Collaboration to Analyze Immunotherapy Resistance
Read more
Thought Leadership
September 13, 2024
OncoHost accepted to present poster at ESMO 2024
Read more
August 16, 2024
OncoHost announces three abstracts selected for presentation at WCLC 2024
Read more
July 30, 2024
Matching Patients with Treatments: Developing Clinically Meaningful Diagnostics To Inform Cancer-Immunotherapy Selection
Read more
August 2, 2024
Ninety-three percent of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test
Read more
August 5, 2024
Clinical Lung Cancer publishes study: 93% of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test
Read more
July 29, 2024
New Test Influences First-Line Therapy Decisions for Metastatic NSCLC Patients
Read more
June 18, 2024
Immunotherapy Month…and Much More
Read more
June 18, 2024
OncoHost: Finding New, Better Immunotherapies for Complex Cancers
Read more
May 27, 2024
Israeli Startup To Showcase AI Cancer Tool At Top Oncology Summit
Read more
May 27, 2024
PROphet Platform’s Predictive Ability to be Demonstrated
Read more
May 31, 2024
OncoHost To Present Poster Demonstrating PROphet®’s Application in Multiple Cancer Indications at ASCO 2024
Read more
June 10, 2024
Dana-Farber Cancer Institute and OncoHost partner for renal cell carcinoma research
Read more
June 12, 2024
Companies partner to identify biomarkers for renal cell carcinoma
Read more
June 3, 2024
OncoHost Launches Study on Biomarkers for Renal Cell Carcinoma
Read more
June 3, 2024
OncoHost and Dana-Farber Partner on Kidney Cancer (RCC) Biomarker Study
Read more
June 4, 2024
OncoHost announces new study on biomarkers for renal cell carcinoma
Read more
June 2, 2024
Leading Cancer institute Dana-Farber to partner with OncoHost for groundbreaking cancer study
Read more
May 17, 2024
OncoHost on liquid biopsy, AI, and developing Israel’s life sciences ecosystem
Read more
May 20, 2024
Biomed 2024 Showcases Israel’s Resilient Entrepreneurial Spirit
Read more
April 10, 2024
AI tool helps doctors pick optimum cancer treatment for patients
Read more
March 29, 2024
Observational study demonstrates clinical validity and utility of OncoHost’s PROphet NSCLC test
Read more
March 22, 2024
Study in JCO® Precision Oncology Validates Clinical Efficacy of OncoHost’s PROphet® NSCLC Test
Read more
March 21, 2024
Study Demonstrates Clinical Validity of OncoHost’s NSCLC Test
Read more
March 21, 2024
OncoHost Wins AI Excellence Award
Read more
February 26, 2024
Predicting immunotherapy success via biomarkers
Read more
February 22, 2024
New cancer research for personalized care
Read more
February 22, 2024
Study: Protein Indicates Likely Success of Cancer Immunotherapy
Read more
January 26, 2024
OncoHost’s CEO Is PROphet-ic About His Diagnostic’s Potential To Transform Care
Read more
January 15, 2024
OncoHost: Guiding oncology treatment decisions with one blood draw
Read more
January 4, 2024
Predicting Immune-Related Adverse Events Through Machine Learning With OncoHost: Dr. Waqas Haque, Dr. Matthew Hadfield, and Dr. Ofer Sharon
Read more
April 4, 2022
AI & Big Data - A Bright New Diagnosis? Roundtable
Read more
December 8, 2019
First-Of-Its-Kind Lab To Improve Personalized Cancer Therapy Opens In Israel
Read more
December 31, 2019
Israeli algorithm may predict if cancer patients will respond to treatment
Read more
January 21, 2020
OncoHost, RayBiotech Win $1M From BIRD Foundation
Read more
January 21, 2020
OncoHost, RayBiotech Awarded $1 Million Grant for Precision Oncology
Read more
February 5, 2020
Top 5 Recent Advances In Israeli Cancer Research And Treatment
Read more
February 10, 2020
Startup develops blood test that aims to undermine tumors’ resilience
Read more
February 18, 2020
Backed by EU funds, Israeli researcher tackles treatment-resistant cancer
Read more
February 23, 2020
$8m in BIRD grants go to Israeli-US collaborations in agtech and health
Read more
March 1, 2020
Personalized Cancer Treatment, A Real Possibility?
Read more
April 7, 2020
Developing Personalized Strategies To Maximize Cancer Therapy Success
Read more
June 4, 2020
PART 1: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients
Read more
June 4, 2020
PART 2: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients
Read more
August 7, 2020
By Next Year, Will Doctors Finally Have The Technology To Fully Personalize Treatments For Lung Cancer Patients?
Read more
October 6, 2020
OncoHost Data on Host Immunotherapy Response to be Presented This Week
Read more
November 4, 2020
Oncohost platform improves immunotherapy response predictions
Read more
November 12, 2020
Israeli blood test offers better choices to fight cancer
Read more
November 15, 2020
OncoHost Offers New Hope For Cancer Sufferers
Read more
December 8, 2020
Dr. Ofer Sharon, CEO of OncoHost – Interview Series
Read more
December 31, 2020
OncoHost - Personalized cancer therapy for more effective treatment
Read more
January 12, 2021
Nobel prizewinner Ciechanover hails ‘much more precise’ cancer treatment
Read more
January 19, 2021
Israeli Startup OncoHost Raises $8M For AI Precision Oncology Platform
Read more
January 19, 2021
Israel-based OncoHost closes $8M in Series B funding to provide personalized cancer therapy for more effective treatment
Read more
January 19, 2021
OncoHost Raises $8 Million in Series B Funding Round
Read more
January 19, 2021
OncoHost raises $8 million to develop AI that predicts cancer treatment responses
Read more
January 20, 2021
OncoHost Secures $8M in Series B Funding
Read more
January 20, 2021
The evolution of machine learning in oncology: an interview with Dr Ofer Sharon
Read more
January 21, 2021
Money on the Move: January 15-20
Read more
January 26, 2020
US-Israel Foundation To Invest $8M In 9 New Joint Initiatives
Read more
January 21, 2021
OurCrowd leads $8M Series B in Israeli personalized cancer therapy startup
Read more
January 22, 2021
Oncohost nabs $8M series B round for AI-powered precision oncology platform
Read more
January 22, 2021
OncoHost Secures $8 Million Series B Funding Round
Read more
January 26, 2021
Health IT Appointments and Hires
Read more
February 1, 2021
January 2021 smiles upon Israeli startups: 4 new Unicorns and over $1B in funding
Read more
February 17, 2021
Dr. Ofer Sharon, CEO of OncoHost, Discusses Technology to Improve Cancer Care
Read more
March 30, 2021
How an AI tool predicts responses to cancer treatment
Read more
May 21, 2021
Which Israeli technologies will soon be going to space?
Read more
June 14, 2021
The Impact of Technology on Healthcare
Read more
June 16, 2021
NHS opens eight UK clinical trial sites to assess cancer patient response to immunotherapy in collaboration with OncoHost
Read more
June 16, 2021
NHS Opens Eight UK Clinical Trial Sites to Assess Cancer Patient Response to Immunotherapy in Collaboration with OncoHost
Read more
June 16, 2021
NHS opens 8 clinical trial sites to assess cancer treatment
Read more
June 17, 2021
Israel’s OncoHost, UK’s NHS to study cancer patient responses to immunotherapies
Read more
June 22, 2021
Oncohost opens trial sites for study evaluating its AI proteomics profiling technology
Read more
July 6, 2021
OncoHost's Focus on the Patient Offers Precision Oncology to Combat Cancer
Read more
August 19, 2021
OncoHost awarded Best Practices Technology Innovation Leadership Award in the AI-based precision oncology industry by Frost & Sullivan
Read more
August 20, 2021
OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices
Read more
August 25, 2021
Israeli Startup OncoHost Eyeing 2022 Commercial Launch of Immunotherapy Response Prediction Test
Read more
September 20, 2021
OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response
Read more
September 20, 2021
Oncohost platform predicts response to lung cancer therapy
Read more
October 31, 2021
OncoHost’s Algorithms Predict Cancer Patients Response To Treatments
Read more
November 1, 2021
CTech’s 20 Minute Leaders Podcast Interview with Ofer Sharon, CEO of OncoHost
Read more
November 6, 2021
OncoHost: Personalizing cancer treatment based on host response
Read more
November 15, 2021
Dr. Ofer Sharon, CEO of OncoHost, Talks the Potential Impact of Precision Medicine on Cancer Therapy
Read more
December 1, 2021
OncoHost: David Gandara
Read more
December 7, 2021
Health IT Appointments and Hires
Read more
December 13, 2021
OncoHost, Heidelberg University Hospital Strike Lung Cancer Biomarker Alliance
Read more
December 16, 2021
Global Roundup: Aussie Biopharma Raises $25 Million to Expand in US
Read more
December 17, 2021
Israeli research institute makes great contributions to cancer research
Read more
December 20, 2021
OncoHost Collaborates with Lung Biobank Heidelberg to Discover Lung Cancer Biomarkers
Read more
January 17, 2022
OncoHost Announces Interim Results From PROPHETIC Trial, Multicenter Assessment Of NSCLC Patient Response To Immunotherapy
Read more
January 24, 2022
Space meat and hummus: Israel finalizes experiments for upcoming ISS mission
Read more
January 24, 2022
Next Israeli astronaut’s 35 experiments revealed
Read more
January 28, 2022
2022 Predictions for AI and Machine Learning in Healthcare
Read more
February 3, 2022
3 Researchers Developing Innovative Strategies In Cancer Therapy
Read more
March 1, 2022
Oncology Peer Review On-The-Go: Ofer Sharon, MD, Discusses OncoHost and PROPHETIC Trial for NSCLC
Read more
March 2, 2022
Tech Transfer Roundup: MD Anderson, Moffitt Lead Busy Academic Cancer Partnering Space
Read more
March 14, 2022
Lifting the veil of uncertainty around cancer treatments
Read more
March 16, 2022
Driving Progress in Personalized Cancer Therapy
Read more
March 23, 2022
Nobel laureate Prof. Aaron Ciechanover to discuss advances in precision medicine
Read more
April 5, 2022
OncoHost Announces AI-Based Clinical Trial Collaboration to Analyze Immunotherapy Resistance
Read more
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
In the News
September 13, 2024
OncoHost accepted to present poster at ESMO 2024
Read more
August 16, 2024
OncoHost announces three abstracts selected for presentation at WCLC 2024
Read more
August 5, 2024
Clinical Lung Cancer publishes study: 93% of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test
Read more
August 2, 2024
Ninety-three percent of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test
Read more
July 30, 2024
Matching Patients with Treatments: Developing Clinically Meaningful Diagnostics To Inform Cancer-Immunotherapy Selection
Read more
July 29, 2024
New Test Influences First-Line Therapy Decisions for Metastatic NSCLC Patients
Read more
June 18, 2024
OncoHost: Finding New, Better Immunotherapies for Complex Cancers
Read more
June 18, 2024
Immunotherapy Month…and Much More
Read more
June 12, 2024
Companies partner to identify biomarkers for renal cell carcinoma
Read more
June 10, 2024
Dana-Farber Cancer Institute and OncoHost partner for renal cell carcinoma research
Read more
June 4, 2024
OncoHost announces new study on biomarkers for renal cell carcinoma
Read more
June 3, 2024
OncoHost and Dana-Farber Partner on Kidney Cancer (RCC) Biomarker Study
Read more
Show more
Thought Leadership
February 13, 2024
Unlocking the Potential of AI-Driven Biomarkers: A New Era in Personalized Cancer Care
Read more
June 12, 2023
A Multicomponent Biomarker Approach Will Shift Cancer Care
Read more
February 27, 2023
A New Approach to Personalized Immunotherapy
Read more
November 29, 2022
Bringing Hope to Patients with Stage IV Non–Small-Cell Lung Cancer
Read more
October 25, 2022
This Time, It’s Personal
Read more
August 30, 2022
Collaboration is the key to advancing cancer care
Read more
May 31, 2022
How Can We Investigate Biomarkers For Lung Cancer Patients More Effectively?
Read more
March 22, 2021
Revealing the Blind Spot in Cancer Treatment with Host Response Profiling
Read more
January 13, 2021
Treating cancer with precision: It’s time for host response profiling
Read more
February 13, 2020
Cancer Therapy in 2020: The promise of host-response profiling
Read more
Press Releases
January 21, 2020
OncoHost and RayBiotech Awarded $1 Million Grant From the BIRD Foundation to Advance Precision Oncology for Patients Receiving Immunotherapy
Read more
January 21, 2020
BIRD - Israel-U.S. Binational Industrial R&D Foundation to Invest $8 million in 9 New Projects
Read more
December 4, 2019
OncoHost Opens First-of-its-Kind Proteomics Laboratory for Host Response Analysis for Cancer Therapy
Read more
October 31, 2019
OncoHost: Nature Reviews Cancer Article Outlines Host Response Analysis as New Tool for Precision Medicine in Oncology
Read more
Previous
Meetings & Events
No items found.
Awards
March 20, 2024
2024 Artificial Intelligence Excellence Award
Read more
December 3, 2023
Top 10 Precision Oncology Solution Providers 2023
Read more
October 5, 2023
2023 Merit Awards for Technology: Gold Winner in Biotech
Read more
March 15, 2023
Biotechnology Awards 2023: Best Precision Oncology Solutions Developer - Middle East
Read more
January 11, 2023
2023 BIG Innovation Award for PROphet® Platform
Read more
November 1, 2021
Health Tech Digital Awards 2021
Read more
September 30, 2021
ESMO 2021 Best Poster Award: Biomarker Category
Read more
September 27, 2021
Semifinalist: AACC Disruptive Technology Awards 2021
Read more
August 18, 2021
Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices
Read more
.png)
.png){kind=logo}
